Ghent University Academic Bibliography

Journal Article
A1
open access

Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial

Thomas Zilli, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2026) EUROPEAN UROLOGY ONCOLOGY.

Add to list

Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer

Lies Van den Eynde (UGent) , Piet Ost (UGent) , Wesley Verla, Wouter Everaerts, Karen Fransis, Pieter Uvin, Filip Ameye, Thomas Van Erps, Valerie Fonteyne (UGent) , Charles Van Praet (UGent) , et al.

(2025) BJU INTERNATIONAL. 136(6). p.1121-1127

Add to list

Does surgical skill rely on surgical specialty or training method? A randomised controlled trial

Ruben De Groote, Stefano Puliatti, Marco Amato, Elio Mazzone, Giuseppe Rosiello, Rui Farinha, Artur Paludo, Liesbeth Desender (UGent) , Ben Van Cleynenbreugel, Wouter Everaerts, et al.

(2025) BJU INTERNATIONAL. 136(1). p.9-11

Add to list

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, Francois-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2025) LANCET ONCOLOGY. 26(6). p.695-706

Add to list

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468

Add to list

Journal Article
A2
open access

Discrimination, reliability, sensitivity, and specificity of robotic surgical proficiency assessment with global evaluative assessment of robotic skills and binary scoring metrics : results from a randomized controlled trial

Ruben De Groote, Stefano Puliatti, Marco Amato, Elio Mazzone, Alessandro Larcher, Rui Farinha, Artur Paludo, Liesbeth Desender (UGent) , Nicolas Hubert, Ben Van Cleynenbreugel, et al.

(2023) ANNALS OF SURGERY OPEN. 4(3).

Add to list

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Elke Rammant (UGent) , Ann Van Hecke (UGent) , Karel Decaestecker (UGent) , Maarten Albersen, Steven Joniau, Wouter Everaerts, Femke Jansen, Nihal E. Mohamed, Roos Colman (UGent) , Mieke Van Hemelrijck, et al.

(2022) PSYCHO-ONCOLOGY. 31(2). p.219-226

Add to list

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Charlien Berghen, Steven Joniau, Piet Ost (UGent) , Kenneth Poels, Wouter Everaerts, Karel Decaestecker (UGent) , Karin Haustermans, Gaëtan Devos and Gert De Meerleer

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(2). p.305-309

Add to list

Miscellaneous
open access

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas Zilli, Piet Dirix, Reino Heikkila, Nick Liefhooghe, Shankar Siva, Alfonso Gomez-Iturriaga, Wouter Everaerts, Francois Otte, Mohamed Shelan, Carole Mercier, et al.

(2021) EUROPEAN UROLOGY FOCUS. 7(2). p.241-244

Add to list

Journal Article
A1
open access

Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines

Boudewijn Dullens, Robin de Putter (UGent) , Matteo Lambertini, Angela Toss, Sileny Han, Els Van Nieuwenhuysen, Toon Van Gorp, Adriaan Vanderstichele, Chantal Van Ongeval, Machteld Keupers, et al.

(2020) JOURNAL OF ONCOLOGY. 2020.

Academic Bibliography

Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial

Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer

Does surgical skill rely on surgical specialty or training method? A randomised controlled trial

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Discrimination, reliability, sensitivity, and specificity of robotic surgical proficiency assessment with global evaluative assessment of robotic skills and binary scoring metrics : results from a randomized controlled trial

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines

Contents

Support

Contact